GlassScriptPhysician profile
Ganesh R Murthy
NPI 1851702187
$8,091.46
in general payments reported to CMS, 2019-2025
34 companies · $812 in 2025
The $812 reported for 2025 was more than what a typical Epilepsy provider received nationally (typical 2025 total: $366).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.05 · 2021: $2,520 · 2022: $1,953 · 2023: $1,765 · 2024: $1,029 · 2025: $812.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,191 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $400 · Education: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,191.27 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $400.00 |
| Education | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $2,541.11 | 2021-2025 | Vns Therapy Sentiva Model 1000 Generator, Vns Therapy |
| Sk Life Science, INC. | $1,018.31 | 2021-2025 | |
| Abbvie INC. | $881.82 | 2021-2023 | |
| Ucb, INC. | $613.50 | 2021-2025 | Briviact, Fintepla, Rystiggo |
| Neuropace, INC. | $522.26 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $485.15 | 2022-2025 | Epidiolex |
| Sunovion Pharmaceuticals INC. | $220.61 | 2021-2022 | |
| Neurelis, INC. | $219.73 | 2021-2025 | Valtoco |
| Medtronic, INC. | $205.64 | 2022-2024 | Percept PC Brainsense |
| Roche Diagnostics Corporation | $123.43 | 2024 | |
| Catalyst Pharmaceuticals, INC. | $120.19 | 2024 | |
| Alexion Pharmaceuticals, INC. | $116.13 | 2021-2023 | Ultomiris |
| Monteris Medical Corporation | $102.63 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $98.11 | 2022 | |
| Eisai INC. | $84.76 | 2020-2021 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $82.53 | 2021-2023 | Ajovy |
| Pacira Pharmaceuticals Incorporated | $70.51 | 2023 | Iovera |
| Amgen INC. | $65.06 | 2021-2022 | |
| Pfizer INC. | $63.63 | 2023 | |
| Lundbeck LLC | $58.95 | 2021-2023 | Vyepti |
| Lilly USA, LLC | $58.10 | 2021-2022 | |
| Biogen, INC. | $56.36 | 2021-2023 | Spinraza |
| Sumitomo Pharma America, INC. | $47.71 | 2023 | Aptiom |
| Janssen Pharmaceuticals, INC | $38.32 | 2022 | |
| Neurocrine Biosciences, INC. | $28.96 | 2021 | |
| Csl Behring | $25.46 | 2023 | Hizentra |
| Argenx US, INC. | $23.68 | 2023 | Vyvgart |
| Alnylam Pharmaceuticals INC. | $21.57 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $19.32 | 2021 | |
| Xeris Pharmaceuticals, INC. | $19.14 | 2022 | |
| Zogenix INC. | $18.07 | 2021 | |
| Boston Scientific Corporation | $15.90 | 2023 | |
| Ipsen Biopharmaceuticals, INC | $12.81 | 2021 | |
| Collegium Pharmaceutical, INC. | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ganesh Murthy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.